Paradigm Biopharmaceuticals Limited announced that Ms. Abby Macnish Niven has been appointed Interim Chief Financial Officer (CFO) following the resignation of Mr. Justin Cahill from the role. Abby Macnish Niven, the Company's current Company Secretary, has been appointed Interim CFO, effective from Friday 3 March 2023. She is the part-time CFO and Company Secretary for two other ASX listed companies.

She has a bachelor's degree in science and commerce from the University of Western Australia and is a Chartered Financial Analyst® charter-holder. Justin is available to support the team and ensure an orderly CFO transition.